Katalyze AI Announces $10.5M Seed Round

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Katalyze AI, the agentic operating system for pharmaceutical companies, recently announced $10.5 million in seed funding led by Bonfire Ventures, along with Inovia Capital, Ripple Ventures, Alumni Ventures, and leading angel investors including Gokul Rajaram and Farzad Soleimani. Katalyze’s platform lets any scientist, engineer, or analyst in a biopharma company build teams of agents that take on real engineering, scientific, and manufacturing work.

Katalyze AI is an OBIO® member and an alumnus of our Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence.

Read more
Arsheen Kaur
Previous

NodeAI Spotlighted in Canadian Healthcare Technology
Next

Renewed Momentum for the RNA Sector in Québec with Nearly $11M in Additional Funding for AReNA